Dr. Cyrus D. Mozayeni is co-founder, President and CEO of Vedere Bio and Entrepreneur-in-Residence at Atlas Venture. Prior to Vedere, he was co-founder of CODA Biotherapeutics, and Oncorus (NASDAQ: ONCR) where he served as President and CBO. Prior to Oncorus, Cyrus served as VP and global head of business development and alliance management at bluebird bio (NASDAQ: BLUE), where his efforts led to a clinical-stage CAR T-cell program (ABECMA®, idecabtagene vicleucel) in collaboration with Celgene, and a successful IPO. Cyrus earned his Sc.B. in neuroscience from Brown University, his M.D. from the University of Virginia School of Medicine and his MBA from the Kellogg School of Management at Northwestern University. He is a licensed physician, and a Fellow of the Academy of Wilderness Medicine.